Evaluation of tubal patency with hysterosalpingo-contrast sonography using sodium alginate solution and the subsequent fertility outcomes in repeat breeder cattle
Journal of Reproduction and Development · 2025
DOI: 10.1262/jrd.2025-052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Reproduction and Development, 2025. Verfasst von Kazuki Ito und 3 weiteren Autor:innen. Beteiligte Einrichtung: Veterinary Clinic, Saitama Agricultural Mutual Aid Association, Saitama 360-0843, Japan. Hauptthemen laut MEDLINE: Alginates, Fallopian Tubes, Fallopian Tube Diseases, Fertility. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Ito Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Veterinary Clinic, Saitama Agricultural Mutual Aid Association, Saitama 360-0843, Japan.
- Laboratory of Veterinary Reproduction, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan.
Förderung
- Ito Foundation
Zitieren
APA
Ito, K., Hashimoto, R., Endo, N., & Tanaka, T. (2025). Evaluation of tubal patency with hysterosalpingo-contrast sonography using sodium alginate solution and the subsequent fertility outcomes in repeat breeder cattle. Journal of Reproduction and Development. https://doi.org/10.1262/jrd.2025-052
Vancouver
Ito K, Hashimoto R, Endo N, Tanaka T. Evaluation of tubal patency with hysterosalpingo-contrast sonography using sodium alginate solution and the subsequent fertility outcomes in repeat breeder cattle. Journal of Reproduction and Development. 2025. doi:10.1262/jrd.2025-052
BibTeX
@article{Ito2025,
author = {Ito, Kazuki and Hashimoto, Ryuji and Endo, Natsumi and Tanaka, Tomomi},
title = {Evaluation of tubal patency with hysterosalpingo-contrast sonography using sodium alginate solution and the subsequent fertility outcomes in repeat breeder cattle},
journal = {Journal of Reproduction and Development},
year = {2025},
doi = {10.1262/jrd.2025-052}
}
EUVIMED